Purine derivative

Details for Australian Patent Application No. 2005247601 (hide)

Owner Glaxo Group Limited

Inventors Blatcher, Philip; Cousins, Richard Peter Charles; Evans, Derek Norman

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005247601

PCT Pub. Number WO2005/116037

Priority 0411563.0 24.05.04 GB; 0509521.1 10.05.05 GB

Filing date 23 May 2005

Wipo publication date 8 December 2005

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/52 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/116037 Priority application(s): WO2005/116037

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247607-Method for producing quaternary ammonium compounds

2005247600-Refuse treatment plant